Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 7.8.2023Chiesi Farmaceutici S.p.A. (CHS)6964DTrimbow 172 mikrogramov/5 mikrogramov/9 mikrogramov, inhalačný roztok v tlakovom obale (sol inh 1x120 dávok/172 µg/5 µg/9 µg (inh.Al))1.8.2023U
 7.8.2023B.Braun Melsungen AG (BME)10440Gelaspan 4% (sol inf 20x500 ml (vak plast.-Ecobag))7.8.2023R
 7.8.2023Neofyt spol. s r.o. (NEF)6281DOcticide 1 mg/g + 20 mg/g dermálny roztokový sprej (aer deo 1x50 ml (fľ.HDPE))14.8.2023R
 7.8.2023Viatris Limited (VIM)95046Meloxicam Viatris 15 mg (tbl 20x15 mg (blis.PVC/PVDC/Al))8.8.2023O
 7.8.2023Noridem Enterprises Ltd. (NID)0853EMetoclopramide Noridem 5 mg/ml injekčný roztok (sol inj 50(10x5)x2ml/10 mg (amp.PP))3.8.2023U
 7.8.2023Reddy Holding GmbH (RDD)1909EValsartan Reddy 320 mg filmom obalené tablety (tbl flm 28x320 mg (blis.OPA/Al/PVC/Al))4.8.2023U
 7.8.2023Reddy Holding GmbH (RDD)1904EValsartan Reddy 160 mg filmom obalené tablety (tbl flm 98x160 mg (blis.OPA/Al/PVC/Al))4.8.2023U
 7.8.2023Reddy Holding GmbH (RDD)1902EValsartan Reddy 160 mg filmom obalené tablety (tbl flm 28x160 mg (blis.OPA/Al/PVC/Al))4.8.2023U
 7.8.2023Reddy Holding GmbH (RDD)1888EValsartan Reddy 80 mg filmom obalené tablety (tbl flm 28x80 mg (blis.OPA/Al/PVC/Al))4.8.2023U
 7.8.2023Reddy Holding GmbH (RDD)1096EBortezomib Reddy 3,5 mg prášok na injekčný roztok (plv ino 1x3,5 mg (liek.inj.skl.))4.8.2023U
 6.8.2023Actavis Group PTC ehf. (ACT-10)5268ANemdatine 10 mg filmom obalené tablety (tbl flm 98x10 mg (blis.PVC/PVDC/Al))30.9.2023R
 6.8.2023Teva B.V. (TEV-NL-4)7318CTacforius 5 mg tvrdé kapsuly s predĺženým uvoľňovaním (cps pld 30x1x5 mg (blis.PVC/PVDC/Al-jednotk.dávka))8.8.2023R
 6.8.2023ratiopharm GmbH (RAT)85145Ratiograstim 30 MIU/0,5 ml injekčný alebo infúzny roztok (sol ijf 5x0,5 ml/300 µg (30 MIU) (striek.skl.napln. s bezp.zar.))14.8.2023R
 4.8.2023Gedeon Richter Plc. (GDN)12061Haloperidol Decanoat-Richter (sol inj 5x1 ml/50 mg (amp.skl.hnedá))4.8.2023R
 4.8.2023Wörwag Pharma GmbH & Co. KG (WGP-1)9140BMagnerot (tbl 200x500 mg (blis.PVC/Al))1.8.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)